
4D Pharma reveals progress in phase 2 trial of live biotherapeutic candidate in bladder cancer
The AIM-traded firm was presenting a trial-in-progress poster at the 2022 American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
The AIM-traded firm was presenting a trial-in-progress poster at the 2022 American Society of Clinical Oncology (ASCO) annual meeting in Chicago.